Company to Continue to Support Storage, Accountability, and Distribution of Ammunition Stocks
(Reston, Va.) March 26, 2018 – Leidos (NYSE: LDOS), a global science and technology leader, was awarded a prime contract by the U.S. Army to continue to provide logistics services to the 1st Theater Sustainment Command (TSC) in support of U.S. Army Central (ARCENT), the Army component of U.S. Central Command (CENTCOM). The single-award cost-plus fixed-fee/cost-plus incentive-fee contract has a one-year base period of performance, five one-year options, and a total contract value of approximately $112 million. Work will be performed in Kuwait.
Since 2011, Leidos has supported munitions storage and resupply efforts by operating the 1st TSC's Theater Storage Area and Ammunition Supply Point activities, including accountability for and distribution of ammunition stocks. Under the follow-on contract, Leidos will apply its expertise in delivering resilient mission logistics services to provide receipt, storage, maintenance, issue and distribution of ammunition.
"We look forward to continuing to support the warfighter with a trusted, engaged and responsive program team with the ability to rapidly adapt to emerging requirements," said Leidos President of Defense & Intelligence Tim Reardon.
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.17 billion for the fiscal year ended December 29, 2017. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended December 29, 2017, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.